Níveis elevados de transaminases em um caso de coledocolitíase: a importância do reconhecimento deste padrão by Ferri, João Victor Vecchi et al.
Rev Med (São Paulo). 2017 abr.-jun.;96(2):131-3.
131
doi: http://dx.doi.org/10.11606/issn.1679-9836.v96i2p131-133
High levels of transaminases in a choledocholithiasis case:  
the importance of knowing this pattern
Níveis elevados de transaminases em um caso de coledocolitíase:  
a importância do reconhecimento deste padrão
João Victor Vecchi Ferri1, João Peron Moreira Dias da Silva2, Umberto de Oliveira Filho3, 
José Augusto Froner Bicca4, Daniel Brito de Araujo5
Ferri JVV, Silva JPMD, Oliveira Filho U, Bicca JAF, Araujo DB. High levels of transaminases in a choledocholithiasis case: the 
importance of knowing this pattern / Níveis elevados de transaminases em um caso de coledocolitíase: a importância do reconhecimento 
deste padrão. Rev Med (São Paulo). 2017 abr.-jun.;96(2):131-3.
ABSTRACT: Case report of a 34-year-old healthy woman 
diagnosed with symptomatic choledocholithiasis associated with 
elevated results of transaminases without hepatic disease. High 
levels of these enzymes can occur in choledocholithiasis cases 
without further causes of liver injury. Clinicians must be aware 
of this phenomenon, avoiding unnecessary investigation and its 
consequences.
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RESUMO: Relato de caso de uma mulher hígida de 34 anos de 
idade diagnosticada com coledocolitíase sintomática associada 
a elevados níveis de transaminases, sem doença hepática. Altos 
valores destas enzimas podem ocorrer na coledocolitíase sem 
outra causa de lesão hepática concomitante. Os médicos devem 
estar atentos a este fenômeno, a fim de se evitar investigação 
desnecessária e suas consequências.
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CASE PRESENTATION
A 34-year-old caucasian woman was hospitalized due to abdominal pain, nausea, and jaundice. 
Laboratory exams showed elevated levels of alanine 
aminotransferase (670 U/L), aspartate aminotransferase 
(383 U/L), gamma glutamyl transferase (336 U/L), 
and bilirubins (7.6 mg/dL). Pain started ten days prior 
to the admission, initially in the upper abdomen, with 
irradiation to the back. Owing to the similarity with an 
acute pancreatitis pain pattern, amylase and lipase were 
ordered, but resulted normal. The patient had negative 
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history of hepatic diseases, risk factors for non-alcoholic 
steatohepatitis nor use of hepatotoxic medications that 
could explain such high levels of liver enzymes.
It was performed an abdominal ultrasound, which 
revealed multiple gallstones smaller than 10 mm and a 
choledochal dilatation of 11 mm, without any evidence of 
obstruction or liver morphologic changes (Figure 1).
During hospitalization, the patient had favorable 
evolution, with improvement of abdominal pain and 
jaundice, and progressive decrease of liver enzymes 
levels (Graphic 1). The patient underwent an open 
cholecystectomy with intraoperative cholangiography 
which did not show signs of obstruction (Figure 2), with 
hospital discharge in the day after surgery.
Figure 1. Multiples gallstones demonstrated by an abdominal 
ultrasound on patient’s admission
Graphic 1. Progressive decrease of transaminases while canaliculi enzymes increase
Figure 2. Passage of contrast through the dilated common bile 
duct and duodenum with no signs of stones 
DISCUSSION
High leve ls  of  t ransaminases  dur ing  a 
choledocholithiasis is not a common situation. Therefore, 
it isn’t unusual that experienced physicians start an 
investigation for liver diseases such as viral or autoimmune 
hepatitis, and drug toxicity.
According to Mossberg and Ross1, there are three 
main mechanisms to explain the elevation of transaminases 
after a biliary obstruction: (1) regurgitation of transaminases 
from obstructive biliary canaliculi into hepatic sinusoids, 
(2) increased production and secretion of transaminases 
by liver cells following increased intrabiliary pressure, 
and (3) retention of bile acids leading to necrosis and/or 
apoptosis of hepatocytes. Spivey et al.2 concluded that the 
bile salt-induced liver toxicity was due to mitochondrial 
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disfunction, resulting in depleted ATP levels and sustained 
influx of Ca2+ leading to hepatocyte necrosis.
Although our patient had a high risk for 
choledocholithiasis based on the predictors of the 
American Society for Gastrointestinal Endoscopy, 
our service did not dispose of endoscopic retrograde 
cholangiopancreatography (ERCP), thus we performed an 
intraoperative cholangiography during cholecystectomy, 
which showed no residual calculi (Figure 2)3.
Transaminases are typically elevated early in 
the course of a biliary obstruction and, usually after 
the resolution of the obstructive process, their levels 
normalizes quickly4. Later, liver tests are elevated in a 
cholestatic pattern, with increases in serum bilirubin, 
alkaline phosphatase, and GGT, exceeding the elevations 
in ALT and AST serum levels. Improving liver blood tests 
combined with symptom resolution suggests that a patient 
with choledocholithiasis has spontaneously passed the 
gallstone, as occurred with our patient5.
A possible confounding factor was the use of 
ketoprofen by the patient in the emergency department, 
since there is the possibility of drug-induced hepatitis in 
less than 1% of the cases. However, the rapid decrease 
in transaminases levels, with normal liver function, 
substantially put away this diagnosis.
In a case series of four patients, Tetangco et al.6 
found high levels of transaminases in non-complicated 
choledocholithiasis cases, with AST up to 1.134 U/L 
and ALT of 1.211 U/L, observing that it differs from 
hepatocellular disease by the rapid decline of transaminases 
levels after biliary opening, as occurred in our case. 
Agahi and McNair7, in a case series of three 
patients with choledocholithiasis and ALT above 1.000 
U/L, agreed that this pattern is virtually diagnostic 
of hepatocellular necrosis, but that it can occur in 
uncomplicated choledocholithiasis cases as well, althought 
it is rarely recognized. Nathwari et al.8, in a more robust 
case series of eighteen patients with same features, 
concluded the same.
High levels of AST has been reported by Fortson 
et al.9, demonstrating levels greater than 600 U/L that 
fell rapidly in 24- to 72-hour period in cholelithiasis and 
choledocholithiasis cases. The highest levels were found 
in choledocholithiasis cases in whom the gallbladder had 
already been removed. An important conclusion was that 
a fall in AST levels did not necessarily mean that the stone 
had passed.
We concluded, as most of the other case series, 
that it is important that clinicians become aware of 
this underrecognized pattern, to avoid unnecessary 
investigation and, consequently, protect the patient from 
unnecessary invasive procedures, such as liver biopsy, as 
well as less complex tests, so costs can be reduced. It does 
not mean that in the proper context and high suspicious 
cases, additional investigation cannot be performed.
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